Warnings and Precautions for Using Amivantamab

Amivantamab (Amivantamab) is an innovative biologic drug used to treat a specific type of non-small cell lung cancer (NSCLC). However, like all medications, warnings and precautions need to be closely followed when usingevantuzumab to ensure safety and optimal treatment effectiveness. The following are the warnings and precautions forevantumumab:

Warning:

1.Drug allergic reaction: Evantumumab may cause severe allergic reactions when used. If patients develop allergy symptoms such as itchy skin, rash, shortness of breath, hives, swelling of eyes or lips, tightness of throat, or difficulty breathing, they should stop taking the medication and seek medical attention immediately. Medical professionals need to be able to manage these reactions, so patients should communicate with their doctors regularly.

2.Pneumonitis and pneumonia-like symptoms: Evantumumab may cause pneumonia or discomfort manifesting as pneumonia symptoms during use. This includes cough, shortness of breath, fever, etc. Patients should inform their doctor immediately if these symptoms occur, as this may require treatment to be suspended or adjusted.

3.Skin Toxicity: Some patients may experience skin inflammation and other skin toxicities, such as pain, redness, rash, etc. while using evantumumab. Patients need to inform their doctor about these symptoms to seek appropriate treatment and advice.

4.Hepatotoxicity: Evantumumab may cause hepatotoxicity when used, manifesting as jaundice, elevated liver enzymes and other symptoms. Patients need to undergo liver function monitoring during treatment to ensure liver health.

5.Hypertension: Evantumumab can cause high blood pressure, so patients need to measure their blood pressure regularly and inform their doctor. In cases of high blood pressure, medication may be needed.

6.Bleeding: Patients may be at increased risk of bleeding when using evantumumab. This may manifest as nosebleeds, bleeding gums, purpura, or other symptoms of bleeding. If patients experience abnormal bleeding, they should notify their doctor immediately.

Notes:

1.Medical monitoring: Patients need to receive regular medical monitoring during the use of evantumumab , including blood tests, liver function tests, pulmonary function tests, etc. This helps to detect and manage any potential adverse effects early.

2.Drug Interactions: Patients need to tell their doctor about other medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with evantuzumab and affect its efficacy or safety.

3.Pregnant and breastfeeding women: Evantumumab may pose risks to pregnant and breastfeeding women. Patients need to use appropriate contraceptive measures while taking evantumumab and inform their doctor if they are pregnant or plan to become pregnant.

4.Heart problems: If patients have heart problems, such as heart disease or irregular heartbeat, they should tell their doctor before using evantumumab. This helps determine the appropriateness of treatment.

5.Infectious Diseases: Use of evantumumab may increase the risk of infection. Patients need to take care to avoid contact with known infected people, maintain personal hygiene, and consult a doctor promptly when symptoms of infection appear.

6.Emotional health: Cancer treatment may have an impact on a patient's emotional health. Patients should work with their doctor to seek psychological support or psychotherapy to cope with emotional stress.

Overall, evantumumab is an innovative drug that has the potential to improve the survival rates of patients with NSCLC. However, patients and doctors need to work closely and follow warnings and precautions to ensure safe use and maximize treatment effectiveness. Patients should speak to their doctor immediately in case of any discomfort or concern to receive appropriate support and advice.

Evantuzumab is not yet available in China, so patients cannot purchase it domestically and need to purchase it through foreign channels. There are only European versions of original drugs available abroad, and the price is relatively high, around 20,000 yuan.